Novartis and the spin-off of Sandoz: strategic insights and visions for the future by Jana Petek
Corporate mergers often attract attention, but it’s the demergers of companies that grab the public’s curiosity. Such was the case with the separation of Novartis and Sandoz last year. To illustrate the impact of this decisive move, IMB welcomed Jana Petek, former CEO and current Global Head of TechOps at Novartis, as a guest speaker.
Petek emphasized Novartis’ strategic aim to enhance its global market position and accelerate the development of innovative therapies. The separation, she explained, positions the company to lead the pharmaceutical industry’s future, focusing on addressing critical global health challenges.
The IMB students sincerely thank Ms. Petek for her valuable insights.
Related news
Publish your comment:
Upcoming events
Are you interested in marketing, advertising and market research? Would you like to learn how to access key marketing data for your academic projects ... >>>
Banka Slovenije in cooperation with the Research Centre of the School of Economics and Business invites you to a seminar ‘Green Transition in the ... >>>
Do you want know other cultures , make friends from around the globe, and create unforgettable memories? UL SEB offers you an incredible chance ... >>>